November 7th, 2019: In the fifth publication of a series in Carrier Management, Dr. Robert Reville of Praedicat Inc. discusses the relevance of the ongoing opioids litigation, comparing it to what came before, through asbestos and tobacco, to what may arise in the future.
While opioids manufacturers aren’t typically covered by insurance, if distributors and retailers are found liable, there will likely be insurance losses. And the problems might not stop there if that type of litigation is pursued for other public health issues, suggest Praedicat executives. Here, they review three candidates: antibiotics overuse, diesel emissions and sugar to help insurers who are asking themselves, “What might be the next opioids? And am I likely to be insuring it?”